October 7, 2021
…they are not all used routinely. “When I was a resident we saw about one child per week with meningitis in San Diego. Most of my residents now have never seen a case. Similarly, they have never seen chickenpox—something that every parent before 1995 could spot a mile away. Polio…
October 18, 2018
…for a novel combination drug therapy for B-cell cancers. The trial is headed by Thomas Kipps, deputy director of research at the Moores Cancer Center. He is hopeful that this research may “allow patients to achieve complete remission and stop therapy altogether.” The university’s San Diego Supercomputer Center received a…
May 18, 2017
…(commonly known as Gleevec), used to treat chronic myeloid leukemia (CML). Prior to the drug’s development, the five-year survival rate for CML patients was around 30 percent; now the ten-year survival rate is around 80 percent. Druker has received the Warren Alpert Prize from Harvard Medical School and the Japan…
April 30, 2015
…this theory would be useful in the real world, so this was an opportunity to show that. The result was the launch of Jacobs’ first San Diego company, Linkabit, and the subsequent launch of Qualcomm, which, he said, “has benefited greatly from so many wonderful students graduating from UCSD.” Jacobs…
August 13, 2020
…to the Food and Drug Administration for approval for wider use. Some of the vaccines will induce soreness at the injection site, just like other vaccines we use. The goal here is to show your immune system what the virus would look like if you got exposed, have the immune…
October 26, 2017
…reality to discover new drugs to treat diseases. Surfing the world to learn more about the communities of microbes that inhabit our bodies. Applying design thinking to complex problems like health care and transportation. These are just a few of the forward-thinking projects by UC San Diego researchers and entrepreneurs…
February 7, 2023
UC San Diego Health’s Center for Transplantation is among the nation’s best in lung, heart, kidney and liver programs, powered by long experience and deep expertise.
November 12, 2015
…buffer period to get used to the fast pace where professors or instructors no longer walk each student through the concept and make sure everyone understands before moving on to new topics.” Gabriele Wienhausen, faculty director of the Teaching + Learning Commons. Photo by Erik Jepsen/UC San Diego Publications But…
May 10, 2018
…of immunotherapy that is used for other types of cancers, but is not standard treatment for basal cell carcinoma. They believed the drug would help Lyon because previous studies suggested it was effective against other cancers with genetic mutations similar to his. It worked. Today, Lyon’s tumors have shrunk by…
January 21, 2021
…Artemis program aims to use innovative technologies to explore more of the lunar surface than ever before, and will serve as a springboard for NASA’s next giant leap—exploration of Mars. “There is so much to learn from going back to the moon,” said Meir. “We're still learning new things every…
